Anti-perspiration activity test

Regulatory reference: FDA “guidelines for effectiveness testing of antiperspirant drug products”, CFR 21 protocol
Claim: Anti-perspirant activity
Application field: Active ingredients, mixtures or finished products.
Description of the test: The test is carried out on 30 volunteers. Pre-treatment cycle of 17 days, treatment cycle with the anti-perspiration product for 4 days, exposure in acclimatized room for the times and in the conditions laid down according to the FDA normative at T 24 hours subsequently to the interruption of the anti-perspiration treatment. Gravimetrical reading with analytical balance at T 24 hours of the treated side against the high non-treated armpit. Report in English with Wilkoxon method statistical analysis.
Posted in Anti-perspirant, Anti-perspirant activity, Claim for OTC
  • 1